Immune Therapeutics Inc (OTCQB:IMUN)

0.0299
Delayed Data
As of 10:31am ET
 -0.0011 / -3.55%
Today’s Change
0.01
Today|||52-Week Range
0.09
+43.75%
Year-to-Date
No recent news for Immune Therapeutics Inc.

Today’s Trading

Previous close0.03
Today’s open0.02
Day’s range0.02 - 0.03
Volume653,667
Average volume (3 months)1,258,711
Market cap$11.5M
Data as of 10:31am ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)+18.18%
Earnings growth (this year)-88.89%
Earnings growth (next 5 years)--
Revenue growth (last year)-78.62%
P/E ratio--
Price/Sales3,128.62
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMay 29, 2013
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$3.5K
Annual profit (last year)-$19.5M
Net profit margin-563,713.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Noreen Griffin
Chief Operating Officer
Rudy J. Williams
Corporate headquarters
Orlando, Florida

Forecasts